Patients with type 2 diabetes who were treated with metformin had a 30% reduction in risk for total knee and total hip replacement, compared with patients who did not receive the drug.
Patients with a high BMI are at a greater risk for complications during and after surgery, but some experts argue that strict BMI cutoffs are arbitrary and can worsen disparities in care.